David M. Mauney M.D., EVP and Chief Business Officer at ZIOPHARM ONCOLOGY INC (ZIOP), bought 4,270 shares at $4.68 ($20K) on 2017-11-08, disclosed to the SEC on 2017-11-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.